Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
World Journal of Clinical Cases|March 19, 2016
Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virusKen Sato, Yuichi Yamazaki, Tatsuya Ohyama, et al.
Gut|September 5, 2006
The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitisYuichi Yamazaki, Satoru Kakizaki, Norio Horiguchi, et al.
World Journal of Clinical Cases|December 18, 2015
Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevirTakayoshi Suga, Ken Sato, Yuichi Yamazaki, et al.
Clinical Journal of Gastroenterology|November 20, 2022
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatmentSatoshi Takakusagi, Hitoshi Takagi, Yuichi Yamazaki, et al.
Journal of Gastroenterology and Hepatology|June 9, 2011
Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirinMasashi Namikawa, Satoru Kakizaki, Yutaka Yata, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Improvement of Proteinuria due to Combination Therapy with Daclatasvir and Asunaprevir in Hepatitis C Virus-associated Renal Disease without CryoglobulinemiaSatoshi Takakusagi, Ken Sato, Yuhei Suzuki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 3, 2010
Histone deacetylase inhibitors induce cytochrome P450 2B by activating nuclear receptor constitutive androstane receptorDaichi Takizawa, Satoru Kakizaki, Norio Horiguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 20, 2017
Spontaneous remission of hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic hepatitis CKen Sato, Takeshi Kobayashi, Yuichi Yamazaki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2011
Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1Tatsuya Ohyama, Yuichi Yamazaki, Ken Sato, et al.
Hepatology International|August 6, 2011
Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitisHiroki Tojima, Satoru Kakizaki, Takashi Kosone, et al.
Pageof 9